Abstracts

HCV ANTIBODY AVIDITY–BASED METHOD TO ESTIMATE POPULATION-LEVEL INCIDENCE

Accurate hepatitis C virus (HCV) incidence estimates are critical for monitoring progress towards hepatitis C elimination goals which include a reduction in HCV incidence of 80% by 2030. Moreover, incidence estimates can help guide local prevention and treatment programming, particularly in the context of the US opioid epidemic. An inexpensive ($4/sample), Genedia-based HCV IgG antibody…

HIGH KYNURENINE:TRYPTOPHAN RATIO IS ASSOCIATED WITH LIVER FIBROSIS IN HIV INFECTION

The kynurenine:tryptophan ratio (KTR), a marker of tryptophan catabolism, is associated with impaired T-cell function. Higher KTR has been associated with increased mortality, cardiovascular disease, and neurologic conditions in HIV+ persons. Its role in liver fibrosis is unknown. We examined the association of KTR with liver fibrosis in women with and without HIV infection. Serum…

MORTALITY AFTER DIALYSIS INITIATION AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTION

End-stage renal disease (ESRD) is an important extrahepatic manifestation among chronic hepatitis C virus (HCV)-infected individuals. However, there is little information on survival in these patients after initiating dialysis. Our objective was to investigate all-cause mortality among HCV-infected dialysis patients and whether survival differs with HIV and/or hepatitis B virus (HBV) coinfection or HCV treatment.…

SYNDEMIC HIV AND HEPATITIS VIRAL COINFECTIONS AND INCIDENT END-STAGE RENAL DISEASE

Syndemic viral coinfections, including hepatitis B virus (HBV), hepatitis C virus (HCV) and/or HIV have been associated with premature mortality, however there is little data on their impact on chronic comorbidities, including end-stage renal disease (ESRD). We evaluated the association between coinfections and incident ESRD, independent of traditional risk factors. The British Columbia Hepatitis Testers…

PREVALENCE OF HIV AND PATTERNS OF ART USE AMONG US LIVER-TRANSPLANT CANDIDATES

Despite the high burden of liver disease among HIV-infected (HIV+) individuals, the prevalence of HIV among candidates on the US liver transplant waitlist is unknown. Additionally, since the class of antiretroviral therapy (ART), particularly the use of pharmacoenhancers (protease inhibitors, cobicistat) may complicate post-transplant immunosuppression management, it is critical to understand which regimens are commonly…

EARLY ART IN ACUTE HIV LIMITS DETRIMENTAL CX3CR1 MONOCYTES LINKED TO CNS DYSFUNCTION

CX3CR1 on immune cells drives tissue homing. In chronic HIV (CHI), inflammatory and patrolling monocytes express reduced CX3CR1 density compared to uninfected (HIV-) controls. In addition, CX3CR1 on microglia has been reported to have neuromodulatory effects in the brain. We investigated the dynamics of CX3CR1 density on monocyte subpopulations in individuals who initiate combination antiretroviral…

INFLUENCE OF UGT1A1*28 ON RALTEGRAVIR PK/PD IN THE NEAT001/ANRS143 STUDY

Raltegravir (RAL) is metabolised by UGT1A1 and polymorphisms in the UGT1A1 gene have been associated with plasma concentrations in some but not all previous studies. This analysis represents the largest study to date for the effect of UGT1A1 polymorphisms on RAL PK/PD. NEAT001/ANRS143, a randomised study (n=805 participants), demonstrated non-inferiority of first-line darunavir/ritonavir (DRV/r; 800/100…

HORMONAL CONTRACEPTIVES DO NOT ALTER CABOTEGRAVIR PK IN HIV-UNINFECTED WOMEN HPTN 077

Long-acting Injectable Cabotegravir (CAB LA) is a novel strand-transfer integrase inhibitor, currently in development for HIV prevention and treatment. Unexpected drug-drug interactions (DDI) between ARVs and hormones for contraception or cross-sex therapy have been noted for other ARVs, ranging from 13% to 38% reduction in tenofovir exposure (AUC) in the setting of estrogen with or…